Lotus Pharmaceutical Co., Ltd. (1795) Reports Strong Q4 2025 Earnings with EPS of NT$18.14
Lotus Pharmaceutical Co., Ltd. (1795) announced its fourth quarter 2025 financial results, reporting a basic earnings per share (EPS) of NT$18.14. The company achieved quarterly revenue of NT$20.509 billion and a net profit after tax of NT$4.720 billion, solidifying its position as a leading company in Taiwan's biotechnology and healthcare sector.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:20 (16h 20m after Collected)
Lotus Pharmaceutical Co., Ltd., trading under the stock code 1795, has released its financial report for the fourth quarter of 2025. The company, a prominent player in Taiwan's biotechnology and healthcare industry, reported a robust basic earnings per share (EPS) of NT$18.14 for the quarter.
During the fourth quarter of 2025, Lotus Pharmaceutical generated operating revenue amounting to NT$20.509 billion. The net profit after tax for the same period reached NT$4.720 billion.
Company Code: 1795
Company Name: Lotus Pharmaceutical Co., Ltd.
Industry: Biotechnology and Healthcare
Period: Q4 2025
Basic Earnings Per Share: NT$18.14
Operating Revenue: NT$20.509 billion
Net Profit After Tax: NT$4.720 billion
During the fourth quarter of 2025, Lotus Pharmaceutical generated operating revenue amounting to NT$20.509 billion. The net profit after tax for the same period reached NT$4.720 billion.
Company Code: 1795
Company Name: Lotus Pharmaceutical Co., Ltd.
Industry: Biotechnology and Healthcare
Period: Q4 2025
Basic Earnings Per Share: NT$18.14
Operating Revenue: NT$20.509 billion
Net Profit After Tax: NT$4.720 billion
FAQ
What is Lotus Pharmaceutical's stock code?
Lotus Pharmaceutical's stock code is 1795.
What were the key financial highlights for Lotus Pharmaceutical in Q4 2025?
In Q4 2025, Lotus Pharmaceutical reported a basic EPS of NT$18.14, operating revenue of NT$20.509 billion, and a net profit after tax of NT$4.720 billion.
What industry does Lotus Pharmaceutical operate in?
Lotus Pharmaceutical operates in the biotechnology and healthcare industry.